Wanjia Group Holdings Limited (HKG:0401)

Market Cap	35.29M
Revenue (ttm)	161.69M
Net Income (ttm)	-6.62M
Shares Out	560.22M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	71,743
Open	0.0630
Previous Close	0.0630
Day's Range	0.0630 - 0.0630
52-Week Range	0.0420 - 0.1080
Beta	0.61
RSI	26.12
Earnings Date	Jun 20, 2025

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowlo...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 181
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0401

Financial Performance

In 2024, Wanjia Group Holdings's revenue was 161.69 million, a decrease of -10.71% compared to the previous year's 181.09 million. Losses were -6.62 million, -83.45% less than in 2023.